Michael Engsig

Michael Engsig discloses dealings in Nykode Therapeutics ASA to Oslo Børs. Between 31 October 2023 and 24 November 2025, the trades on record add up to 5 filings.

The open-market record is one-sided, with 4 purchases worth €40k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2025: 2 purchases and no sales on the market.

Half of the purchases are above €8,664 and half below. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 24 November 2025, the filings show an open-market purchase worth €8,490 in Nykode Therapeutics ASA. This summary is built from Oslo Børs disclosures alone and does not predict where the share price will go.